QQQ   390.81 (+0.16%)
AAPL   189.33 (-0.56%)
MSFT   379.51 (-0.83%)
META   333.00 (-1.77%)
GOOGL   135.35 (-1.35%)
AMZN   147.01 (-0.01%)
TSLA   246.78 (+0.02%)
NVDA   481.60 (+0.71%)
NIO   7.21 (+0.00%)
BABA   74.99 (-2.28%)
AMD   124.25 (+1.84%)
T   16.32 (+0.87%)
F   10.66 (+2.80%)
MU   76.62 (+0.66%)
CGC   0.56 (+4.37%)
GE   118.91 (+0.05%)
DIS   93.06 (+0.61%)
AMC   7.25 (+8.21%)
PFE   30.06 (+1.25%)
PYPL   58.33 (-0.24%)
XOM   103.63 (-0.26%)
QQQ   390.81 (+0.16%)
AAPL   189.33 (-0.56%)
MSFT   379.51 (-0.83%)
META   333.00 (-1.77%)
GOOGL   135.35 (-1.35%)
AMZN   147.01 (-0.01%)
TSLA   246.78 (+0.02%)
NVDA   481.60 (+0.71%)
NIO   7.21 (+0.00%)
BABA   74.99 (-2.28%)
AMD   124.25 (+1.84%)
T   16.32 (+0.87%)
F   10.66 (+2.80%)
MU   76.62 (+0.66%)
CGC   0.56 (+4.37%)
GE   118.91 (+0.05%)
DIS   93.06 (+0.61%)
AMC   7.25 (+8.21%)
PFE   30.06 (+1.25%)
PYPL   58.33 (-0.24%)
XOM   103.63 (-0.26%)
QQQ   390.81 (+0.16%)
AAPL   189.33 (-0.56%)
MSFT   379.51 (-0.83%)
META   333.00 (-1.77%)
GOOGL   135.35 (-1.35%)
AMZN   147.01 (-0.01%)
TSLA   246.78 (+0.02%)
NVDA   481.60 (+0.71%)
NIO   7.21 (+0.00%)
BABA   74.99 (-2.28%)
AMD   124.25 (+1.84%)
T   16.32 (+0.87%)
F   10.66 (+2.80%)
MU   76.62 (+0.66%)
CGC   0.56 (+4.37%)
GE   118.91 (+0.05%)
DIS   93.06 (+0.61%)
AMC   7.25 (+8.21%)
PFE   30.06 (+1.25%)
PYPL   58.33 (-0.24%)
XOM   103.63 (-0.26%)
QQQ   390.81 (+0.16%)
AAPL   189.33 (-0.56%)
MSFT   379.51 (-0.83%)
META   333.00 (-1.77%)
GOOGL   135.35 (-1.35%)
AMZN   147.01 (-0.01%)
TSLA   246.78 (+0.02%)
NVDA   481.60 (+0.71%)
NIO   7.21 (+0.00%)
BABA   74.99 (-2.28%)
AMD   124.25 (+1.84%)
T   16.32 (+0.87%)
F   10.66 (+2.80%)
MU   76.62 (+0.66%)
CGC   0.56 (+4.37%)
GE   118.91 (+0.05%)
DIS   93.06 (+0.61%)
AMC   7.25 (+8.21%)
PFE   30.06 (+1.25%)
PYPL   58.33 (-0.24%)
XOM   103.63 (-0.26%)

Aviva Share Price, News & Analysis (LON:AV)

GBX 424.60
-3.60 (-0.84%)
(As of 11/28/2023 ET)
Compare
Today's Range
424.60
429.10
50-Day Range
375.60
428.20
52-Week Range
366
467.30
Volume
3.68 million shs
Average Volume
N/A
Market Capitalization
£11.63 billion
P/E Ratio
N/A
Dividend Yield
7.54%
Price Target
GBX 523.80

Aviva MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
19.8% Upside
GBX 508.80 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.15mentions of Aviva in the last 14 days
Based on 17 Articles This Week
Insider Trading
Acquiring Shares
£68.63 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars


AV stock logo

About Aviva Stock (LON:AV)

Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products. It also provides insurance cover to individuals, small and medium-sized businesses for risks associated with motor vehicles and medical expenses, as well as property and liability, such as employers' and professional indemnity liabilities. In addition, the company provides investment management services for institutional pension fund mandates; and manages various retail investment products, including investment funds, unit trusts, open-ended investment companies, and individual savings accounts for third-party financial institutions, pension funds, public sector organizations, investment professionals, and private investors. It markets its products through a network of insurance brokers, as well as MyAviva platform. The company was formerly known as CGNU plc and changed its name to Aviva plc in July 2002. Aviva plc was founded in 1696 and is headquartered in London, the United Kingdom.

AV Stock Price History

AV Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Aviva branches out in Canada with £100m Optiom deal
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Trending tickers: Gold | Salesforce | Snowflake | Aviva
See More Headlines
Receive AV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aviva and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/5 Dividend
8/24/2023
Dividend Payable
10/05/2023
Today
11/29/2023

Industry, Sector and Symbol

Industry
Insurance - Diversified
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
24,364
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 523.80
High Stock Price Target
GBX 560
Low Stock Price Target
GBX 472
Potential Upside/Downside
+23.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
£-636,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£-3,480,000,000.00
Cash Flow
GBX 469.79 per share
Book Value
GBX 333 per share

Miscellaneous

Outstanding Shares
2,740,000,000
Free Float
N/A
Market Cap
£11.63 billion
Optionable
Not Optionable
Beta
0.95
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Ms. Amanda Jayne Blanc ACII (Age 56)
    MBA, Group CEO & Executive Director
    Comp: $3.21M
  • Ms. Charlotte Claire Jones (Age 55)
    Group CFO & Executive Director
    Comp: $994.88k
  • Mr. Nick Amin (Age 67)
    Chief Operating Officer
  • Mr. John Cummings
    Chief Information Officer
  • Ms. Kirstine A. Cooper (Age 59)
    Group General Counsel & Company Secretary
  • Ms. Danielle Harmer (Age 55)
    Chief People Officer
  • Mr. Martin Muir
    Group Chief Capital Officer
  • Mr. Jason Chambers
    Head of Underwriting Transformation
  • Mr. David Dixey
    Chief Underwriting Officer of Commercial, Corporate & Speciality Lines
  • Ms. Louise Soulsby
    Head of Media Relations - UK Life & Pensions














AV Stock Analysis - Frequently Asked Questions

Should I buy or sell Aviva stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aviva in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AV shares.
View AV analyst ratings
or view top-rated stocks.

What is Aviva's stock price target for 2024?

5 Wall Street analysts have issued twelve-month target prices for Aviva's shares. Their AV share price targets range from GBX 472 to GBX 535. On average, they expect the company's share price to reach GBX 508.80 in the next year. This suggests a possible upside of 19.8% from the stock's current price.
View analysts price targets for AV
or view top-rated stocks among Wall Street analysts.

How have AV shares performed in 2023?

Aviva's stock was trading at GBX 442.80 on January 1st, 2023. Since then, AV shares have decreased by 4.1% and is now trading at GBX 424.60.
View the best growth stocks for 2023 here
.

How often does Aviva pay dividends? What is the dividend yield for Aviva?

Aviva announced a dividend on Wednesday, August 16th. Investors of record on Thursday, August 24th will be paid a dividend of GBX 11.10 per share on Thursday, October 5th. This represents a yield of 2.92%. The ex-dividend date is Thursday, August 24th. The official announcement can be seen at this link.
Read our dividend analysis for AV
.

Is Aviva a good dividend stock?

Aviva (LON:AV) pays an annual dividend of GBX 32 per share and currently has a dividend yield of 7.49%. AV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for AV.

What other stocks do shareholders of Aviva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aviva investors own include Lloyds Banking Group (LLOY), Barclays (BARC), Prudential (PRU), Vodafone Group Public (VOD), HSBC (HSBA), Legal & General Group (LGEN), Royal Mail (RMG), Royal Dutch Shell (RDSB), GSK (GSK) and BP (BP).

How do I buy shares of Aviva?

Shares of AV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AV) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -